A labeled neutral endopeptidase inhibitor as a potential tool for tumor diagnosis and prognosis.

MLA

Raguin, Olivier, et al. “A Labeled Neutral Endopeptidase Inhibitor as a Potential Tool for Tumor Diagnosis and Prognosis.” Angewandte Chemie (International Ed. in English), vol. 44, no. 26, June 2005, pp. 4058–61. EBSCOhost, https://doi.org/10.1002/anie.200500700.

APA

Raguin, O., Fournié-Zaluski, M.-C., Romieu, A., Pèlegrin, A., Chatelet, F., Pélaprat, D., Barbet, J., Roques, B. P., & Gruaz-Guyon, A. (2005). A labeled neutral endopeptidase inhibitor as a potential tool for tumor diagnosis and prognosis. Angewandte Chemie (International Ed. in English), 44(26), 4058–4061. https://doi.org/10.1002/anie.200500700

Chicago

Raguin, Olivier, Marie-Claude Fournié-Zaluski, Anthony Romieu, André Pèlegrin, François Chatelet, Didier Pélaprat, Jacques Barbet, Bernard P Roques, and Anne Gruaz-Guyon. 2005. “A Labeled Neutral Endopeptidase Inhibitor as a Potential Tool for Tumor Diagnosis and Prognosis.” Angewandte Chemie (International Ed. in English) 44 (26): 4058–61. doi:10.1002/anie.200500700.